Skip to Content

Health

Ebola Fast Facts

Here’s a look at Ebola, a virus with a high fatality rate that was first identified in Africa in 1976. Facts Ebola hemorrhagic fever is a disease caused by one of five different Ebola viruses. Four of the strains can cause severe illness in humans and animals. The fifth, Reston virus, has caused illness in

Continue Reading

US reports lowest average of daily Covid-19 infections and deaths since March 2020. But experts warn millions are still vulnerable

The US is making significant strides in curbing the coronavirus pandemic just in time for the summer, with reported infections reaching a new low over the last year. The country averaged less than 14,400 daily reported infections and 427 deaths over the past seven days, according to Johns Hopkins University data. It’s the lowest the

Continue Reading

MRSA Fast Facts

Here is some background information about MRSA. Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to all beta-lactam antibiotics such as methicillin, penicillin, oxacillin and amoxicillin. A MRSA infection can be fatal. About Staphylococcus aureus bacteria are commonly found on the skin and in the noses of healthy people. Skin infections from staph bacteria are called

Continue Reading

CDC study finds coronavirus vaccines lead to milder disease in rare breakthrough infections

People who have been vaccinated against coronavirus, if they do become infected, have milder Covid-19 illness than unvaccinated people, a new US Centers for Disease Control and Prevention study shows. The study, which looked at more than 3,900 essential workers, shows fully vaccinated people are more than 90% protected against infection. Even partially vaccinated people

Continue Reading

In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 years

The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer’s disease — despite an FDA advisory committee concluding last year that there is not enough evidence to support the effectiveness of the treatment. The drug was developed for patients with mild cognitive impairment, not

Continue Reading
Skip to content